Denali Therapeutics CEO Ryan Watts' 2020 pay jumps 87% to $9.3M
Denali Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 22, 2021
Denali Therapeutics reported fiscal year 2020 executive compensation information on April 22, 2021.
In 2020, four executives at Denali Therapeutics received on average a compensation package of $5.5M, a 77% increase compared to previous year.
Average pay of disclosed executives at Denali Therapeutics
Ryan J. Watts, Chief Executive Officer, received $9.3M in total, which increased by 87% compared to 2019. 59% of Watts' compensation, or $5.5M, was in option awards. Watts also received $648K in bonus, $589K in salary, $2.6M in stock awards, as well as $11K in other compensation.
Carole Ho, Chief Medical Officer, received a compensation package of $4.3M, which increased by 74% compared to previous year. 49% of the compensation package, or $2.1M, was in option awards.
Steve E. Krognes, Chief Financial Officer, earned $4.3M in 2020, a 69% increase compared to previous year.
Alexander O. Schuth, Chief Operating Officer, received $4.2M in 2020, which increases by 70% compared to 2019.
Related executives
You may also like
Source: SEC filing on April 22, 2021.